Envestnet Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,938
| Closed | -$288K | – | 4428 |
|
|
2025
Q1 | $288K | Sell |
9,938
-22,265
| -69% | -$645K | ﹤0.01% | 3943 |
|
|
2024
Q4 | $1.2M | Sell |
32,203
-2,463
| -7% | -$91.5K | ﹤0.01% | 3046 |
|
|
2024
Q3 | $1.68M | Buy |
34,666
+9,306
| +37% | +$452K | ﹤0.01% | 2777 |
|
|
2024
Q2 | $1.01M | Buy |
25,360
+1,563
| +7% | +$62.5K | ﹤0.01% | 3038 |
|
|
2024
Q1 | $1.04M | Buy |
23,797
+726
| +3% | +$31.9K | ﹤0.01% | 2996 |
|
|
2023
Q4 | $1.43M | Buy |
23,071
+6,146
| +36% | +$380K | ﹤0.01% | 2673 |
|
|
2023
Q3 | $778K | Buy |
16,925
+7,468
| +79% | +$343K | ﹤0.01% | 2989 |
|
|
2023
Q2 | $543K | Buy |
9,457
+380
| +4% | +$21.8K | ﹤0.01% | 3155 |
|
|
2023
Q1 | $340K | Buy |
+9,077
| New | +$340K | ﹤0.01% | 3380 |
|
|
2022
Q3 | – | Sell |
-6,053
| Closed | -$211K | – | 3899 |
|
|
2022
Q2 | $211K | Sell |
6,053
-568
| -9% | -$19.8K | ﹤0.01% | 3562 |
|
|
2022
Q1 | $238K | Buy |
+6,621
| New | +$238K | ﹤0.01% | 3578 |
|
|
2017
Q3 | – | Sell |
-252
| Closed | -$5K | – | 2906 |
|
|
2017
Q2 | $5K | Sell |
252
-18
| -7% | -$357 | ﹤0.01% | 2817 |
|
|
2017
Q1 | $4K | Buy |
270
+77
| +40% | +$1.14K | ﹤0.01% | 2918 |
|
|
2016
Q4 | $4K | Buy |
+193
| New | +$4K | ﹤0.01% | 2898 |
|
|
2016
Q3 | – | Sell |
-9,622
| Closed | -$155K | – | 2902 |
|
|
2016
Q2 | $155K | Hold |
9,622
| – | – | ﹤0.01% | 2221 |
|
|
2016
Q1 | $115K | Buy |
+9,622
| New | +$115K | ﹤0.01% | 2336 |
|